The document discusses 14 proposed novel methods for measuring influenza vaccine effectiveness (IVE). Experts from the DRIVE project brainstormed and prioritized the methods. Rapid near patient diagnostic tests, estimating IVE against non-specific influenza outcomes, and using high-dimensional propensity scores were deemed high priority. Methods like case-only studies and adaptive design were lower priority. The document also lists potential sites for implementing the methods during the 2018/19 influenza season.